Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

The role of medical affairs (MA) and disease-state education has become essential in advancing patient care and supporting ...

PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

What makes a story powerful? Storytelling is becoming more critical than ever. In medical publications, healthcare providers ...

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...

But as AI has become more prevalent, we have started to recognise the advantages and opportunities it offers through a ...

The European Academy of Allergy and Clinical Immunology (EAACI) has launched the first World Anaphylaxis Awareness Day today ...

New Environmental, Social and Governance (ESG) regulations coming into force across the EU in 2025 stand to shift how ...

The Health and Social Care Select Committee plays an important role in influencing policy in health and life sciences – as ...

Communicating complex medical information has the potential to overwhelm patients and caregivers. The key is blending ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug has been recommended by the European Medicines Agency’s human medicines ...

Katie Rose (Consultant – Market Access), Maria Dimitrova (Consultant – HTA) and Samantha Gillard (Director – HTA) provide an ...